These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19954766)
1. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. Zhou L; He XD; Yu JC; Zhou RL; Yang H; Qu Q; Rui JA Am J Surg; 2010 Apr; 199(4):515-21. PubMed ID: 19954766 [TBL] [Abstract][Full Text] [Related]
2. Expression of LAPTM4B in gallbladder carcinoma cells: the role in invasive potential. Zhou L; He XD; Yu JC; Zhou RL; Xiong FX; Qu Q; Rui JA Hepatogastroenterology; 2010; 57(98):207-11. PubMed ID: 20583413 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells. Zhou L; He XD; Yu JC; Zhou RL; Shan Y; Rui JA Surgery; 2011 Jul; 150(1):25-31. PubMed ID: 21429547 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line. Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708 [TBL] [Abstract][Full Text] [Related]
7. [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells]. He J; Shao G; Zhou R Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):348-52. PubMed ID: 12947546 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of c-fos induces expression of the retinoblastoma tumor suppressor gene Rb in transfected cells. Pai SR; Bird RC Anticancer Res; 1994; 14(6B):2501-8. PubMed ID: 7872673 [TBL] [Abstract][Full Text] [Related]
9. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745 [TBL] [Abstract][Full Text] [Related]
11. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Kasper G; Vogel A; Klaman I; Gröne J; Petersen I; Weber B; Castaños-Vélez E; Staub E; Mennerich D Cancer Lett; 2005 Jun; 224(1):93-103. PubMed ID: 15911104 [TBL] [Abstract][Full Text] [Related]
12. Effects of signal regulatory proteinalpha1 on proliferation of hepatocellular carcinoma: a preliminary study. Qin JM; Yan HX; Wan XW; Liu SQ; Zeng JZ; Cao HF; Wu MC; Wang HY Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):244-8. PubMed ID: 15908323 [TBL] [Abstract][Full Text] [Related]
13. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404 [TBL] [Abstract][Full Text] [Related]
14. [Suppression of RASSF1A gene on human esophageal carcinoma cells: experiments in vitro and in vivo]. Zhang TW; Wang SF; Cong DG; Fu SB; Meng XN; Yu L; Wang J Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1214-6. PubMed ID: 17686246 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989 [TBL] [Abstract][Full Text] [Related]
16. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1]. Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716 [TBL] [Abstract][Full Text] [Related]
17. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076 [TBL] [Abstract][Full Text] [Related]
18. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
19. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226 [TBL] [Abstract][Full Text] [Related]
20. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin. Xie XK; Yang DS; Ye ZM; Tao HM Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]